Recursion harnesses AI for large-scale drug discovery, while Summit's betting on a single oncology candidate. How do their ...

Moderna expands beyond vaccines while Recursion bets on AI-driven drug discovery, each with distinct risks, partnerships, and financial profiles.

These aren't for the faint of heart.

Recursion Pharmaceuticals combines artificial intelligence, automation, and biotechnology research across multiple ...

Recursion Pharmaceuticals (RXRX) is back in focus as investors weigh fresh updates on its AI-driven drug discovery platform, along with progress in key clinical assets REC-1245 and REC-4881 and ...

Autonomous AI post-training reached frontier scale for the first time: NVIDIA researchers published a paper showing an AI ...

Cathie Wood's ARK Invest purchased $41.2M in Tesla (TSLA) and $2.3M in Bullish while selling $25.3M in Roku shares. See full trade breakdown here.

The rise of AI has brought an avalanche of new terms and slang. Here is a glossary with definitions of some of the most ...

Artificial intelligence is reshaping nearly every industry, but some of its biggest opportunities are emerging far from ...

A new VentureBeat survey of 145 enterprises finds most have hedged their AI model strategy since the Fable 5 blackout, but ...

Anthropic said on Thursday frontier AI developers should establish a coordinated, verifiable way to slow down or temporarily pause development if advanced systems begin improving themselves faster ...

What happened Security researchers disclosed multiple vulnerabilities affecting Apple AirDrop and Google and Samsung Quick Share that could allow attackers within wireless range to crash or disrupt ...